Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype artists want to admit. Medscape Medical News
Tag: Internal Medicine
Medscape Internist Compensation Report 2026
US internists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Medscape Physician Wealth & Debt Report 2026
Physicians reveal how well their incomes help build family net worth, as well as investment and spending philosophies. Wealth disparities are reported by gender and race. Medscape
Medscape Physician Compensation Report 2026: Positive Signs
US physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Physicians Must Lead AI Integration in Medicine
It’s no longer a question that AI will shape the future of medicine. But it must be accountable and transparent, and physicians must lead its integration into clinical practice, writes AMA’s CEO, John Whyte, MD, MPH. Medscape Internal Medicine
Med Op-Ed: Climate-Induced Runny Nose, Pesky No-Shows, More
The clinical ramifications of longer pollen seasons; seeing deeper meaning in ‘Did Not Attends’; and scientific advances may soon transform glaucoma care. Medscape Medical News
Deciphering Diabetic Dilemmas
The Curbsiders tackle complex diabetes cases to help you learn how to manage hypoglycemia among older adults, retinopathy among pregnant individuals, and steroid-induced hyperglycemia. The Curbsiders
Pill That Slows Aging? Meds May Boost Health Span
Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach chronic disease prevention. Medscape Medical News
Does This Side Effect Spell Doom for the GLP-1’s?
The increased risk for a rare optic nerve disorder may not tarnish the game-changer reputation of the GLP-1 drugs. Medscape
Does This Side Effect Spell Doom for the GLP-1s?
The increased risk for a rare optic nerve disorder may not tarnish the game-changer reputation of the GLP-1 drugs. Medscape
Can Medicare Afford the Perpetual Human?
As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer and healthier life. Medscape Medical News
Going to Mars? Your Body Might Disagree
Astronauts face severe health risks on their journey to Mars, dealing with muscle loss, vision changes, and immune system challenges. Medscape Medical News
GLP-1s Are Crazy Effective — Just Not Cost-Effective
We know they are expensive, but isn’t the cost recouped by the healthcare savings? Dr F. Perry Wilson explains. Medscape
There’s a Sandwich Bag of Plastic in Your Brain
Dr F. Perry Wilson reviews disturbing data about the accumulation of nanoplastics in the human body. Medscape
#DiedSuddenly Was BS: Why Did We Believe It?
A hashtag that gained a lot of traction during the COVID-19 pandemic is, thankfully, in decline, but can we avoid buying into such nonsense again? Medscape
Stress: A New Cancer Risk Factor?
Even everyday stress, the kind that many people experience, impairs the cancer-fighting immune system. Medscape
When Doctors With AI Are Outperformed by AI Alone
Why we may need to rethink how we divide responsibilities between human physicians and AI systems to achieve the goal of synergy. Medscape
23andMe’s Business Woes Raise Privacy Concerns: Ethicist
Ethicist Art Caplan discusses data privacy concerns as troubled DNA testing company 23andMe faces a possible sale of its assets. Medscape Business of Medicine
Healthcare Resolutions for 2025
George Lundberg, MD, on how Americans can focus on the nation’s healthcare, not wealthcare. Medscape Internal Medicine
GLP-1s: Good News, Bad News
Big data show surprising outcomes of GLP-1 receptor agonist therapy. Dr F. Perry Wilson comments. Medscape